Clinical Trial Update: Efficacy and Safety of Pioglitazone and Metformin Combination Therapy in Treating Type 2 Diabetes Mellitus. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of a pioglitazone and metformin combination for Type 2 Diabetes Mellitus. Results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)
• metformin (metformin)

Snippet

Sponsor: Takeda | Conditions: Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2010-03-09